Introduction {#sec1}
============

In recent years, the efficacies of clinical diagnostics, therapeutics, and medicines have emerged due to our better insights and recent advances in the understanding of various biological processes at the cellular and molecular levels.^[@ref1]^ The biology of reactive oxygen and nitrogen species (ROS and RNS, respectively) is linked to the involvement of these intracellular molecular entities in various biological processes.^[@ref1]−[@ref3]^ Endogenous ROS and RNS are formed through various intracellular biochemical processes, including nicotinamide adenine dinucleotide phosphate oxidase and mitochondrial electron transport chain.^[@ref4],[@ref5]^ Exogenous sources (e.g., radiation, air pollutants, and certain redox-active xenobiotics) also cause an elevated level of ROS/RNS in living organisms.^[@ref6]^ ROS/RNS participate in biological processes as immunotoxins as well as immunomodulators, and their effective build-up in a living organism is linked to its generation as the byproducts of aerobic metabolism and the immune system processes.^[@ref7]^ Accumulation of the higher than the optimal level of ROS overhauls the antioxidant mechanisms and attributes to oxidative cellular stress.^[@ref8]^ Mechanisms or the biochemical processes which control the production of intracellular ROS/RNS are not well comprehended, and it is pertinent to develop diagnostic strategies at cellular sites of dysfunction.^[@ref9]^

Among various ROS and RNS that are operational in living organisms, we shall limit our discussions on the strategies for clinical diagnosis of hypochlorous acid (HOCl) as ROS and nitroxyl (HNO) as the RNS for this mini-review. The biochemistry of HOCl helps the neutrophils to kill a wide range of infectious agents.^[@ref10]^ It is produced during an oxidation reaction between the H~2~O~2~ and Cl^--^ ions which is catalyzed by the myeloperoxidase (MPO) enzyme, excreted by neutrophils in its inflammatory state.^[@ref10]^ Even though it plays a defensive role in human health, the elevated levels of HOCl are known to cause tissue damage and several diseases such as obesity, diabetes, atherosclerosis, lung injury, rheumatoid, cardiovascular diseases, neurodegenerative conditions, and various cancers.^[@ref10],[@ref11]^

The chemistry of HNO (nitroxyl) and its conjugated base NO^--^ is rather less explored as compared to HOCl. HNO is the protonated one-electron reduction product of NO and is isoelectronic with an oxygen molecule (O~2~). Unlike HOCl, the knowledge base for insight into the role of HNO in human physiology is still in its infancy. Angeli's salt is the most commonly used chemical for the in situ generations of HNO (rate constant of 4.6 × 10^--4^ s^--1^ (at room temperature)), and this process is favored over a pH range of 4--8.^[@ref12],[@ref13]^ Commercial availability of this salt has helped in developing the mechanistic insights of reactions involving HNO with a particular emphasis on elucidation of the biochemical/physiological role. The linear HNO structure is less stable than the bent form by ca. 67 kcal/mol. Computational studies predicted the possible presence of a triplet state having energy of 18.0--19.0 kcal over the ground singlet state.^[@ref14],[@ref15]^ However, to date, experimental evidence for ^3^HNO is missing. Importantly, for NO^--^ the triplet state (ground state) is more stable than the singlet state by ca. 16 kcal/mol.^[@ref16]^ Thus, the deprotonation process is associated with a change in spin state and is spin forbidden (adiabatic singlet--triplet transition energy is 18.45 kcal/mol),^[@ref17]^ and its generation is a slow process, which is attributed to HNO as the prevalent species (p*K*~a~^HNO^ = 11.4)^[@ref18]^ at physiological pH.

HNO is associated with numerous biological activities with significant therapeutic potential. A series of reports reveal that the alcohol-deterrent drug cyanamide (NH~2~CN) is really a prodrug for HNO, an inhibitor of the aldehyde dehydrogenase enzyme.^[@ref19]^ HNO has unique positive lusitropic and ionotropic effects in heart failure without a chronotropic effect and shows favorable effects in ischemia-reperfusion injury. Recent studies also reveal the role of HNO in cancer therapy.

Considering such significances, reagents for efficient recognition, quantification, and mapping of intracellular HOCl and HNO-inappropriate organelles or quantification in suitable biofluids are highly desired. This has attracted much attention among the researchers who are active in the area of chemical biology, environmental science, and clinical diagnostics. In recent years, a number of reports on fluorogenic receptors describing specific detection of these two analytes have appeared. In this short account, we shall limit our discussion only to the recently reported chemodosimetric receptors for HOCl and HNO. There is a recent account published by Wu, Chen, Yoon, and their co-workers on receptors that are specific toward HOCl. Those examples shall be avoided in this mini-review to avoid any repetition.

Results and Discussion {#sec2}
======================

Receptors for HOCl {#sec2.1}
------------------

HOCl is an efficient antimicrobial ROS with high oxidizing potential and is commonly produced in higher eukaryotes. HOCl oxidizes amino acids containing amines and sulfurs; in particular, methionine residues are oxidized to the corresponding methionine sulfoxide. The conversion of methionine sulfoxide is an efficient one with reaction rate approaching the diffusion limit. Recent studies reveal that a HOCl-specific transcription factor (HypT) contributes to HOCl resistance by upregulating the biochemical synthesis of three methionine residues (Met123, Met206, and Met230). This oxidizing efficiency of HOCl is being largely utilized for developing various chemodosimetric molecular probes.

Yang and his team reported an aqueous-soluble *p*-methoxyphenol derivative (**1**) as the dual-signaling (colorimetric and fluorimetric) chemodosimetric probe for HOCl in aqueous PBS buffer (pH 7.4) medium ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}).^[@ref20]^ Following oxidation of **1** to the corresponding quinonoid derivative, a distinct change in the absorption maxima from 314 to 393 nm was observed with an associated reduction in the emission quantum yield at 388 nm. Other ROS and RNS species (H~2~O~2~, ^1^O~2~, O~2~^•--^, ^•^OH, ^•^NO, ONOO^--^, and ROO^•^) failed to induce, and detectable changes in the optical spectrum for **1** and these data ensured specificity of this reagent toward HOCl. This was one of the initial reports on HOCl recognition. Presumably, the luminescence quenching process was the deterrent factor for the authors for exploring the option of using this reagent for intracellular studies.

![Recognition process for HOCl by the reagent **1**.](ao9b03420_0001){#fig1}

Chen et al. reported the iridium(III) complex (**2**) having an oximated 2,2′-bipyridine for detection of ClO^--^.^[@ref21]^ A facile C=N--OH isomerization was attributed to an efficient nonradiative decay process and the poor emission quantum yield ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}). Selective oxidation of the oxime to an aldehyde or carboxylic acid, induced by ClO^--^, caused a luminescence ON response having a luminescence maximum at 578 nm (λ~ex~ = 346 nm) in DMF:aq. HEPES buffer medium (pH 7.2). An oxidized carboxy derivative showed a bright orange-yellow luminescence coming from from \[5d(Ir) → π\*(bpy)\] ^3^MLCT and \[π(ppy) → π\*(bpy)\] ^3^LLCT triplet excited states. The authors ensured the specificity of the reagent **2** toward ClO^--^ in the presence of other common ROS species. Moreover, the use of test strips comprising **2** showed very promising sensitivity to ClO^--^. Similar oxime based probes **3** and **4** were also reported for specific detection of ClO^--^.^[@ref22],[@ref23]^

![Molecular structures of chemosensors **2**--**4**.](ao9b03420_0002){#fig2}

A similar methodology was utilized for developing a rhodamine-based luminophore (**5**), and this was further explored for mapping of the endogenous HOCl in live HeLa cells ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}).^[@ref24]^

![(i) Molecular structure for reagent **5** and (ii) fluorescence and bright-field microscopy images of cells. (a) Fluorescence microscopy image of cells incubated with **5** (20 μM) for 30 min. (b) Fluorescence microscopy image of cells pretreated with **5** (20 μM) for 30 min and then incubated with OCl^®^ (200 μM) for 30 min. (c) Bright-field microscopy image of the cells shown in panel b. (d) Overlay image of (b) and (c). [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}(ii) was reprinted from ref ([@ref24]). Copyright 2011 Royal Society of Chemistry.](ao9b03420_0003){#fig3}

Loo, Zhang, and co-workers reported a hybrid upconversion luminescence (UCL) detection system (**6**) for HOCl ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}).^[@ref25]^ Upconverting luminescence nanoparticles (UCNP) are generally preferred over conventional luminescent molecular probes owing to their stability toward photobleaching, deeper tissue penetration of the near-infrared (NIR) active radiation, minimal or no self-induced fluorescence, and less tissue damage.^[@ref26]−[@ref28]^ The extent of loading of the rhodamine-based oxidizable receptor was calculated as ∼5.81 wt %. The amino-terminated rhodamine derivative was loaded onto the surface of UCNPs via interactions with oleic acid (OA) termini. Polyacrylic acid (PAA) was further used to replace OA ligands from the surface of UCNPs, which not only helped in creating an aqueous-soluble triple-layer nanostructure but also prevented the rhodamine derivative from detachment from the UCNP surface. Upon reaction of **6** with HOCl, there was a gradual decrease in green emission from UCL with concomitant increase in the rhodamine-based emission due to the conversion of the cyclic lactam from an acyclic xanthene form through an efficient FRET-based energy transfer process. This ratiometric response was successfully utilized for mapping intracellular HOCl that was released by MPO-mediated peroxidation of chloride ions in living cells. A similar probe **7** was further reported by Xu et al. for specific detection of HOCl.^[@ref29]^

![(a) Schematic representation of the hybrid UCNP-based recognition of HOCl and the molecular structures for **6** and **7**. (b) Ratiometric UCL images of NIH3T3 cells: the cells preincubated with hybrid-UCNPs in the MPO enzymatic system (MPO enzyme, 2.0 U/100 mL; NaCl, 250 mM) for 30 min at 37 °C and then further incubated with 100 μM H~2~O~2~ for 180 min (i--iv). Emissions were collected by the green UCL window at λ~500--560~ nm (i and v) and red UCL window at λ~600--700~ nm (iii and vii) with excitation at 980 nm. Overlay of bright-field and green channel UCL images shown in the panel (ii and vi). The ratiometric UCL intensities of NIH3T3 cells (iv and viii) were examined by using IPP software. [Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}b was reprinted from ref ([@ref25]). Copyright 2014 John Wiley and Sons.](ao9b03420_0004){#fig4}

The sulfur-containing rhodamine derivatives showed greater selectivities for OCl^--^ than those of Se and Te. In 2007, Nagano and co-workers presumably were the first to demonstrate this using an appropriate S-functionalized rhodamine derivative (**8**).^[@ref30]^ Authors have also demonstrated the use of this reagent for mapping the hypochlorous acid that was created inside phagosomes in real time ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}).

![(a) Molecular structure of **8** and (b) CLSM images of porcine neutrophil: (i) zymosan particles are near the neutrophil, (ii) the neutrophil engulfs the zymosan, and (iii) phagocytosis is complete. The [Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}b was reprinted from ref ([@ref30]). Copyright 2007 American Chemical Society.](ao9b03420_0005){#fig5}

The authors have reported a formylhydrazine derivative of rhodamine B (**9**) for specific recognition of intracellular HOCl in live RAW 264.7 macrophage cells ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}).^[@ref31]^

![(a) Molecular structure of reagent **9** and (b) fluorescence microscopy images of live RAW 264.7 macrophage cells: (i, iv, and vii) are bright-field images; (ii, v, and viii) are of red channel at 570--670 nm) with excitation at 533 nm; and (iii, vi, and ix) are the merged images. [Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}b was reprinted from ref ([@ref31]). Copyright 2019 American Chemical Society.](ao9b03420_0006){#fig6}

A single conjugated flexible polymer having reactive centers for HOCl and target-inert fluorophores was designed. This far-red to NIR nanoprobe (**10**) helped in identifying intracellular HOCl through a FRET-based ratiometric detection ([Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}).^[@ref32]^ Reagent **10** was successfully used for mapping of HOCl fluctuations in macrophage cells. The dual-emission property of **10** enabled a more sensitive mapping of ClO^--^ in peritonitis in mice with high contrast.

![(a) Schematic presentation of the chemodosimetric detection of ClO^--^ and (b) CLSM images of exogenous ClO^--^ in MCF-7 cells: MCF-7 cells were first incubated with **10** (10 μg/mL) overnight at 37 °C and then were incubated with 80 μM NaClO. CLSM images were acquired in the green channel (530--600 nm) and red channel (\>650 nm) with λ~ex~ = 405 nm. [Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}b was reprinted from ref ([@ref32]). Copyright 2017 American Chemical Society.](ao9b03420_0007){#fig7}

The azo functionality having an *o*-amino group substituted in a phenyl ring undergoes selective oxidation with HOCl to produce a triazole functionality. This was utilized in developing Ru(II)-polypyridyl-based luminescent sensors (**11** and **12**) for HOCl ([Figure [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"}).^[@ref33]^

![Molecular structures of probes **11** and **12**. The proposed mechanism of the probe toward hypochlorous acid.](ao9b03420_0008){#fig8}

BODIPY derivative (**13**, [Figure [9](#fig9){ref-type="fig"}](#fig9){ref-type="fig"}) was used successfully for mapping endogenously produced HOCl in RAW 264.7 macrophages.^[@ref34]^ Wide-field and super-resolution structured illumination microscopy (SR-SIM) images confirmed localization of the reagent in the Golgi complex and lysosomes. Importantly, reagent **13** was found to be suitable with 3D-SIM imaging of a single cell.

![(a) Schematic presentation of the chemodosimetric detection of ClO^--^ by the reagent **13**. (b) SR-SIM images of RAW 264.7 cells (i) incubated with **13** as control for 30 min, (ii) incubated with **13** and further exposed to 10 μM HOCl for 20 min. (c) 3D-SIM images of endogenously generated HOCl and reduced signal spread generated by lipopolysaccharide stimulation (2500 ng) detected by **13** (10 μM). (i and ii) Signal detection on punctured structures, (ii--iv) signal spread from punctures to diffuse structures, (v) shows more diffuse structures than punctures signifying total signal transfer to diffuse structures from punctures, and (vi) signal saturation due to less accessibility of endogenous HOCl (indication of cell death). (d) Dual-color SR-SIM and 3D-SIM using **13** in the presence of lipopolysaccharide and Hoechst 33442. [Figure [9](#fig9){ref-type="fig"}](#fig9){ref-type="fig"}(b--d) was reprinted from ref ([@ref34]). Copyright 2018 Royal Society of Chemistry.](ao9b03420_0009){#fig9}

### Two-Photon Reagents for HOCl Recognition {#sec2.1.1}

Presumably, the first two-photon (TP) active reagent for HOCl was reported by Chang and co-workers.^[@ref35]^ The first TP-active reagents (**14** and **15**) that were specific for imaging HOCl in the mitochondria (**14**) and lysosome (**15**) are shown in [Figure [10](#fig10){ref-type="fig"}](#fig10){ref-type="fig"}.^[@ref35]^ These probes showed good selectivity toward HOCl. In particular, the TP imaging of **14** and **15** in the murine model revealed that the elevated amount of HOCl could be identified in both the mitochondria and lysosome of macrophage cells under inflammation conditions. Thus, these reagents could be utilized to understand the roles of HOCl at subcellular levels.

![Molecular structure for receptors (a) **14** and **15** and (b) detection of lipopolysaccharide-dependent HOCl production in inflammation tissues via **14** and **15**. An amount of 200 μL of lipopolysaccharides (1 mg/mL) was hypodermically injected into the right rear paws of the mouse to cause inflammation. After 1 day, 200 μL of 1 mM **14** (or **15**) was intravenously injected, and the paw skin was sectioned 1 h later. (c) CLSM images of reagent and CD11b in the inflamed tissue. Reagent fluorescence, green; antibody CD11b, red. Arrows signify the merged parts of HOCl-sensitive probes and CD11b. Scale bar: 30 μm. [Figure [10](#fig10){ref-type="fig"}](#fig10){ref-type="fig"}(b,c) was reprinted from ref ([@ref35]). Copyright 2015 American Chemical Society.](ao9b03420_0010){#fig10}

A new TP fluorescent probe (**16**) having a pendant imidazoline-2-thione as an OCl^--^ identification unit and triphenylphosphine as a mitochondrial-targeting group were reported.^[@ref36]^ The precise reaction among imidazoline-2-thione and OCl^--^® accounted for the luminescence ON response and the basis for specific recognition even in the presence of other ROS species. This TP-active reagent **16** was utilized to image endogenously created mitochondrial OCl^--^ in live HeLa, HepG2, and RAW 264.7 cells via TP microscopy ([Figure [11](#fig11){ref-type="fig"}](#fig11){ref-type="fig"}). Despite being TP-active, this reagent was not utilized for tissue imaging.

![(a) Schematic presentation of the chemodosimetric detection of ClO^--^ by the reagent **16**. (b) TPM images of (i, iv) HeLa cells, (ii, v) astrocytes, and (iii, vi) HepG2 cells labeled with 10 μM **16** (i--iv) before and (iii--vi) after pretreatment with 200 μM NaOCl for 30 min. The TPM was collected at 400--600 nm upon excitation at 700 nm with femtosecond pulses. Scale bars: (upper) 48 μm and (lower) 18 μm. [Figure [11](#fig11){ref-type="fig"}](#fig11){ref-type="fig"}b was reprinted from ref ([@ref36]). Copyright 2017 American Chemical Society.](ao9b03420_0011){#fig11}

The two-photon activity of the naphathalimide derivative was utilized for developing a lysosome-specific luminescent molecular probe (**17**) that had morpholine functionality as the lysosome-targeting group.^[@ref37]^ Reagent **17** was oxidized to the corresponding sulfoxide species by ClO^--^ with an associated luminescence OFF response. Unlike other examples, this reaction triggered an OFF response, which could be revived by GSH.

The naphthoimidazolium borane derivative (**18**) participated in an electrophilic oxidation mechanism associated with B--H bond degradation to yield a TP-active naphthoimidazolium derivative.^[@ref38]^ This reagent could be utilized for monitoring of endogenously produced HOCl and the changes in endoplasmic reticulum during oxidative stress situations. Endogenous OCl^--^ mapping in macrophages was then studied. Macrophages were stimulated by lipopolysaccharides (LPS) and interferon γ (IFN-γ). MPO was attributed to an in situ generation of OCl^--^ and was further treated with phorbol myristate acetate (PMA). These studies confirmed the efficacy of the reagent for recognition of intracellular OCl^--^ through TP microscopy ([Figure [12](#fig12){ref-type="fig"}](#fig12){ref-type="fig"}).

![(a) Molecular structures for reagents **17** and **18**. (b) Pseudocolored ratiometric TPM images of Raw 264.7 cells labeled with **18** (10 μM) for 30 min: (i) control image. Cells pretreated with (ii) tunicamycin (known to increase oxidative stress of the ER (10 μg mL^--1^, 16 h)) through generation of H~2~O~2~, (iii) dithiothreitol that consumes H~2~O~2~ in the ER and reduces oxidative stress (2 mM, 16 h), (iv) lipopolysaccharides (100 ng mL^--1^, 16 h), interferon-γ (50 ng mL^--1^, 4 h), and phorbol myristate acetate (10 nM, 30 min), (v) lipopolysaccharides, interferon-γ, phorbol myristate acetate, and 4-aminobenzoic acid hydrazide (a MPO inhibitors) (50 μM, 4 h), and (vi) lipopolysaccharides, interferon-γ, PMA, and FFA (50 μM, 4 h) and then treated with **18** (λ~ex~ = 720 nm), and TP microscopy images were acquired at 450--600 nm (green) and 380--430 nm (blue) channels. The scale bar is 20 μm. [Figure [12](#fig12){ref-type="fig"}](#fig12){ref-type="fig"}b was reprinted from ref ([@ref38]). Copyright 2017 American Chemical Society.](ao9b03420_0012){#fig12}

Guo and co-workers have reported a series of reagents for intracellular quantification of HOCl by introducing a bioorthogonal dimethylthiocarbamate receptor ([Figure [13](#fig13){ref-type="fig"}](#fig13){ref-type="fig"}).^[@ref39]^ The authors have successfully demonstrated the role of the S atom in designing this set of molecular probes ([Figure [13](#fig13){ref-type="fig"}](#fig13){ref-type="fig"} a). Among these, reagent **19** is found to be the most efficient one, while allowing a ratiometric luminescence response on a specific reaction with HOCl at high risk pathogenic concentrations (0.47 mM). This reagent showed 48-fold enhancement in the ratio for *I*~468 nm~/*I*~630 nm~ with a good linear relationship. The release of the thiocarbamate moiety of **19** on reaction with HOCl led to the generation of the corresponding phenol derivative having a luminescence maximum of 468 nm. The formation of the phenolic derivative induced an excited-state intramolecular proton transfer and intramolecular charge transfer processes to result in a 468 nm luminescence. The authors could demonstrate the use of this reagent for monitoring the oxidative stress process induced by elesclomol in live cancer cells ([Figure [13](#fig13){ref-type="fig"}](#fig13){ref-type="fig"}b).

![(a) Scheme for demonstrating the role of the S atom in the chemodosimetric recognition process and the molecular structure for reagent **19** with illustration of the photoinduced processes that are associated with the ratiometric luminescence response. (b) Intracellular localization of **19** in HepG2 cells: CLSM imaging of HepG2 cells incubated with 20 mM **19** and then stained with MitoTracker Green FM (200 nM), LysoTracker Green DND-26 (7.5 nM), and Golgi Tracker Green (NBD C6-ceramide, 3 mM), respectively. Red channel: λ~ex~ = 405 nm, λ~em~ = 610--650 nm. Green channel: λ~ex~ = 488 nm, λ~em~ = 490--550 nm. The scale bar is 10 mm. [Figure [13](#fig13){ref-type="fig"}](#fig13){ref-type="fig"}b was reprinted from ref ([@ref39]). Copyright 2019 Royal Society of Chemistry.](ao9b03420_0013){#fig13}

Various Receptors for HNO {#sec3}
=========================

Initially it was perceived that HNO chemical biology was similar to NO as a biological conciliator. Unfavorable redox potential does not allow a facile reduction of NO to HNO in physiological conditions. However, moderate H--NO bond strength (50 kcal mol^--1^) makes HNO a more efficient hydrogen atom donor than many other biological antioxidants. This may potentially react with the appropriate ROS/RNS-based radical species to generate NO, which subsequently reacts, oxidizing radical species to quench.^[@ref40]^ There is a recent short account on receptors that are specific toward HNO published by Lin and co-workers. We shall be avowing any appreciable overlap with examples that are discussed in this mini-review.

Thus, the reactivity and biological implications of HNO and NO are not similar; it is worth knowing some of the early reports by Lippard and co-workers in NO recognition. These results have certainly helped researchers in understanding the clinical biology of HNO and are mentioned briefly before discussing some of the recent efforts on HNO recognition.

Lippard's group reported a series of Cu(II) complexes for the detection of NO and were almost silent toward HNO. One of the representative Cu(II) complexes (**20**) is shown in [Figure [14](#fig14){ref-type="fig"}](#fig14){ref-type="fig"}. These probes were successfully imaged NO in HeLa cells and RAW 264.7 macrophages.^[@ref41]^ Luminescence response of **20** toward NO was specific. Experimental studies revealed that the NO-triggered fluorescence enhancement for 19 happened through generation of Cu(I) with subsequent dissociation to a luminescent secondary amine N--NO derivative.

![(a) Molecular structures of probe **20**. (b) CLSM imaging of HNO in HeLa cells. The left image corresponds to the treatment of cells with the reagent **20**. The right side image corresponds to cells treated with Angeli's salt. Scale bar = 25 μm. [Figure [14](#fig14){ref-type="fig"}](#fig14){ref-type="fig"}b was reprinted from ref ([@ref41]). Copyright 2013 American Chemical Society.](ao9b03420_0014){#fig14}

To explicate the factors that impart the selectivity for nitroxyl (HNO) over nitric oxide (NO) among the metal-based fluorescent reagents, Lippard and co-workers had studied a series of Cu(II)-cyclam derivatives, and the one (**21**) that showed most positive reduction potential of the series promoted reduction of Cu(II) ([Figure [15](#fig15){ref-type="fig"}](#fig15){ref-type="fig"}).^[@ref42]^ Generation of Cu(I) with necessary structural changes to adjust and stabilize the tetrahedral Cu(I) center was stated to be crucial and attributed to a luminescence ON response. It is worth mentioning that reduction of the nitrosonium cation (NO^+^) to NO occurs at 1.52 V (vs NHE) and fails to reduce Cu(II) in **21**. This is attributed to the specificity toward HNO over NO. Lippard and co-workers have developed another Cu(II) complex (**22**) of the mixed thia/aza 14-N~2~S~2~ ligand, which was found to react reversibly with HNO at pH 7.^[@ref43]^

![(a) Molecular structure of probes **21** and **22**. (b) CLSM images of HeLa cells incubated with **21** in aq. PBS buffer solution before and after addition of Angeli's salt: (i) differential interference contrast image, (ii) blue channel image showing nucleus, (iii) NIR channel prior to the addition of Angeli's salt, and (iv) NIR channel 5 min after treatment with 1.5 mM Angeli's salt. The scale bar is 25 μm. [Figure [15](#fig15){ref-type="fig"}](#fig15){ref-type="fig"}b was reprinted from ref ([@ref42]). Copyright 2014 American Chemical Society.](ao9b03420_0015){#fig15}

Nakagawa et al. introduced a rhodamine-based HNO specific probe **23** utilizing diphenylphosphine as a response site. HNO reacted with the probe to yield a luminescent rhodamine derivative ([Figure [16](#fig16){ref-type="fig"}](#fig16){ref-type="fig"}).^[@ref44]^

![(a) Molecular structure of probe **23**. (b) HNO-induced CLSM images of A549 cells stained with 1 μM **23** before (left) and 15 min (right) after treatment with 2 μL of Angeli's salt in 10 mM aq. NaOH solution (200 μM). Scale bar = 20 μm. [Figure [16](#fig16){ref-type="fig"}](#fig16){ref-type="fig"}b was reprinted from ref ([@ref44]). Copyright 2013 American Chemical Society.](ao9b03420_0016){#fig16}

An analogous methodology was utilized by Lin et al. for developing reagents (**24**--**26**) that were sensitive to HNO and showed turn ON luminescence response.^[@ref45]^ Diphenylphosphine as a responsive site was exploited for designing these receptors. The reagents could show various emission colors from green to NIR in response to HNO in aqueous solution and inside the cells ([Figure [17](#fig17){ref-type="fig"}](#fig17){ref-type="fig"}). For the first time, by incubating the living cells with these reagents simultaneously, we demonstrate the multicolor imaging of HNO with emission colors in the range of green to NIR in living systems. Furthermore, reagent **27** showed large turn-on NIR fluorescence signal upon excitation in the NIR region. This reagent was also used successfully for detection of HNO in living mice. The same research group has exploited a similar approach for developing another rhodamine derivative for recognition of intracellular HNO.^[@ref46]^

![(a) Chemical structures of the molecular probes **24**--**26**. CLSM images of living HeLa cells: (b) bright-field image of live HeLa cells after incubation with **24** (5.0 μM), **25** (10 μM), and **26** (5.0 μM) for 20 min, then with Angeli's salt (200 μM) for 45 min; (c) CLSM image of (b), λ~ex~ = 405 nm, emission channel of 470--570 nm; (d) CLSM image of (b), λ~ex~ = 559 nm, emission channel of 600--680 nm; (e) CLSM image of (b), λ~ex~ = 635 nm, emission channel of 690--780 nm. The scale bar is 10 μm. (f) The chemical structure of the probe **26** and its chemodosimetric reaction. [Figure [17](#fig17){ref-type="fig"}](#fig17){ref-type="fig"}(b--e) was reprinted from ref ([@ref45]). Copyright 2016 Royal Society of Chemistry.](ao9b03420_0017){#fig17}

A similar reaction was utilized by Das and co-workers for developing another reagent **28**.^[@ref47]^ This reagent showed high specificity toward HNO and localization at the endoplasmic reticulum of RAW 264.7 cells. This photophysical property of this reagent was found to be well-suited for its use in SR-SIM and two-color SIM imaging, permitting more than one organelle to be imaged at SR-SIM ([Figure [18](#fig18){ref-type="fig"}](#fig18){ref-type="fig"}). The option of using this probe for in vivo imaging application was exhibited using a small marine invertebrate model, Artemia. Designed substitution at the pyrrole ring with extended conjugation helped in achieving a luminescence response with maximum at longer wavelength (586 nm).

![(a) Molecular structure of the reagent **28**, (b) luminescence spectral profile to show the specificity of the reagent toward **28** and its concentration-dependent intensity variation, (c) dual-color (i) SIM and (ii) comparative wide-field CLSM images with Hoechst as the nuclear stain (pseudo coloring has been employed in all the images) and **28** as the ER-specific stain. [Figure [18](#fig18){ref-type="fig"}](#fig18){ref-type="fig"}(b,c) was reprinted from ref ([@ref47]). Copyright 2017. American Chemical Society.](ao9b03420_0018){#fig18}

The analogous methodology was adopted for developing another new BODIPY derivative (**29**) for specific recognition of HNO.^[@ref48]^ The hydrophobic interior of an amphiphilic copolymer (mPEG-DSPE; DSPE: 1,2-dimyristoyl-*sn*-glycero-3-phosphoethanolamine-*N*-(methoxy(polyethylene glycol)-2000) was utilized for encapsulating the reagent **29** to prepare a micellar nanoprobe. This reagent showed a ratiometric luminescence response on specific reaction with HNO. Reagent **29** showed efficient cellular internalization and was effectively used to detect HNO in living HepG2 cells, as well as in zebrafish larvae ([Figure [19](#fig19){ref-type="fig"}](#fig19){ref-type="fig"}).

![(a) Molecular structure of the reagent **29** and its reaction product, (b) CLSM images of HepG2 cells incubated with **29** (10 μM) for 30 min (i--v) and then with Angeli's salt (50 μM) for another 10 min (v--viii). (i, v) Bright-field imaging, (ii, vi) green window (510--550 nm), (iii, vii) red window (590--650 nm), and (iv, viii) ratio/merge image obtained from the red window to green window. Scale bar = 20 μm. [Figure [19](#fig19){ref-type="fig"}](#fig19){ref-type="fig"}b was reprinted from ref ([@ref48]). Copyright 2018, American Chemical Society.](ao9b03420_0019){#fig19}

As discussed earlier, the reactivity of HNO with biological thiols reaches the diffusion control limit with rate constants ∼10^9^ M^--1^ s^--1^. To address this, Chan and co-workers had reported a new thiol-based reagent (**30**) that had the potential to compete against reactive thiols for HNO.^[@ref49]^ The molecular structure and the luminescent reaction product are shown in [Figure [20](#fig20){ref-type="fig"}](#fig20){ref-type="fig"}. Treatment of **30** with an HNO donor resulted in a 16-fold enhancement in luminescence intensity. Authors have argued that this reagent showed improved specificity over various ROS/RNS species and efficacy in the presence of biothiols (e.g., glutathione in mM concentrations).

![(a) Molecular structure of the reagent **30** and its reaction product, (b) response of the reagent **30** to various reactive oxygen, sulfur, and nitrogen species at concentrations of 100 μM (GSH was tested at 1 mM), (c) CLSM images of MDA-MB-231 cells treated with (i) 0 μM (vehicle control), (ii) 250 μM, (iii) 500 μM, and (iv) 1000 μM Angeli's salt for 15 min using a 488 nm laser source for excitation. [Figure [20](#fig20){ref-type="fig"}](#fig20){ref-type="fig"} (b and c) was reprinted from ref ([@ref49]). Copyright 2017 American Chemical Society.](ao9b03420_0020){#fig20}

Conclusions {#sec4}
===========

Significant advances are achieved in designing appropriate receptors for HOCl and HNO, and some of the initial and most recent examples are summarized in this short account. However, more concerted efforts are still needed to design the probe for efficient application in clinical biology and therapeutics. To date, there are only a few examples that are either NIR-active or TP-active. Such reagents open up the possibility of developing more efficient reagents. It is argued that one of the unanswered questions in the field of HNO pharmacology/physiology remains: is HNO endogenously generated as a physiological effector/mediator? A question which could, perhaps, be addressed by developing a reagent that tracks/maps the HNO generated through endogenous biosynthesis during cardiovascular stress. Researchers have not addressed the query: how can HNO discriminate between thiol proteins? Addressing such unanswered questions would help in developing an insight into understanding the proper physiological function for HNO---which in turn would help us in designing appropriate and efficient receptors for HNO. The chemistry of HOCl is a little better understood. Still, there are many unanswered questions for the physiological role of HOCl, and the area of clinical diagnosis of endogenous HOCl still needs attention. Better insight into the HOCl defense mechanism at the molecular level and effective real-time quantification of endogenous HOCl would help not only in controlling many pathogenic bacteria by counteracting them but also for developing efficient molecular probes for HOCl.
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